Literature DB >> 8437105

Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys.

N K Mello1, J B Kamien, S E Lukas, J H Mendelson, J M Drieze, J W Sholar.   

Abstract

In previous studies, daily buprenorphine administration significantly reduced cocaine self-administration by rhesus monkeys over 15 to 120 days (Mello et al., 1990, 1992). This report describes the effects of 60 days of intermittent buprenorphine (0.40 mg/kg) treatment once every 48 hr or 72 hr on cocaine and food self-administration by six rhesus monkeys. Cocaine (0.05 or 0.10 mg/kg/injection) and food (1-g banana pellet) self-administration were maintained on a fixed ratio 4, (variable ratio 16:S) reinforcement schedule. Intermittent buprenorphine treatment reduced cocaine self-administration significantly below saline treatment levels (P < .01). On the first day of buprenorphine treatment, cocaine self-administration averaged 53 and 60% below base line (P < .01-.0001). Cocaine self-administration remained significantly below base line on day 2 (P < .02-.0001) but usually returned to base-line levels by day 3. During buprenorphine treatment once every 48 hr, cocaine self-administration gradually increased over time in four monkeys (P < .001-.0005). These data suggest that intermittent buprenorphine treatment is less effective than daily buprenorphine treatment in reducing cocaine self-administration by rhesus monkeys. Food self-administration decreased by 23.6 and 12.7% from the saline base line during buprenorphine treatment every 48 and 72 hr, respectively. On the day of buprenorphine treatment, food self-administration was usually significantly lower than during the saline base line (P < .05-.0001), but usually returned to or exceeded base line levels by days 2 and 3. There were no significant changes in food self-administration over time with intermittent buprenorphine treatment every 48 hr.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437105

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys.

Authors:  Jennifer L Newman; S Stevens Negus; Anthony Lozama; Thomas E Prisinzano; Nancy K Mello
Journal:  Exp Clin Psychopharmacol       Date:  2010-10       Impact factor: 3.157

2.  Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims.

Authors:  J K Staley; R B Rothman; K C Rice; J Partilla; D C Mash
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

3.  Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.

Authors:  E C Strain; M L Stitzer; I A Liebson; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 4.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

5.  Effects of concurrent saccharin availability and buprenorphine pretreatment on demand for smoked cocaine base in rhesus monkeys.

Authors:  S D Comer; V R Hunt; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.